Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia - PubMed (original) (raw)
. 2001 Mar 23;276(12):9519-25.
doi: 10.1074/jbc.M010144200. Epub 2000 Dec 18.
Affiliations
- PMID: 11120745
- DOI: 10.1074/jbc.M010144200
Free article
Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia
C Chen et al. J Biol Chem. 2001.
Free article
Abstract
Oncogenic transformation and hypoxia both induce glut1 mRNA. We studied the interaction between the ras oncogene and hypoxia in up-regulating glut1 mRNA levels using Rat1 fibroblasts transformed with H-ras (Rat1-ras). Transformation with H-ras led to a substantial increase in glut1 mRNA levels under normoxic conditions and additively increased glut1 mRNA levels in concert with hypoxia. Using a luciferase reporter construct containing 6 kilobase pairs of the glut1 promoter, we showed that this effect was mediated at the transcriptional level. Promoter activity was much higher in Rat1-ras cells than in Rat1 cells and could be down-regulated by cotransfection with a dominant negative Ras construct (RasN17). A 480-base pair (bp) cobalt/hypoxia-responsive fragment of the promoter containing a HIF-1 binding site showed significantly higher activity in Rat1-ras cells than in Rat1 cells, suggesting that Ras might mediate its effect through HIF-1 even under normoxic conditions. Consistent with this, Rat1-ras cells displayed higher levels of HIF1-alpha protein under normoxic conditions. In addition, a promoter construct containing a 4-bp mutation in the HIF1 binding site showed lower activity in Rat1-ras cells than a construct with an intact HIF1 binding site. The activity of the latter construct but not the former could be down-regulated by RasN17, supporting the importance of the HIF1 binding site in regulation by Ras. The phosphatidylinositol 3-kinase inhibitor LY29004 down-regulated glut1 promoter activity and mRNA levels under normoxia and also decreased HIF1alpha protein levels in these cells. Collectively these results indicate that H-Ras up-regulates the glut1 promoter, at least in part, by increasing HIF-1alpha protein levels leading to transactivation of promoter through the HIF-1 binding site.
Similar articles
- Induction of glucose transporter 1 expression through hypoxia-inducible factor 1alpha under hypoxic conditions in trophoblast-derived cells.
Hayashi M, Sakata M, Takeda T, Yamamoto T, Okamoto Y, Sawada K, Kimura A, Minekawa R, Tahara M, Tasaka K, Murata Y. Hayashi M, et al. J Endocrinol. 2004 Oct;183(1):145-54. doi: 10.1677/joe.1.05599. J Endocrinol. 2004. PMID: 15525582 - Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin.
Hudson CC, Liu M, Chiang GG, Otterness DM, Loomis DC, Kaper F, Giaccia AJ, Abraham RT. Hudson CC, et al. Mol Cell Biol. 2002 Oct;22(20):7004-14. doi: 10.1128/MCB.22.20.7004-7014.2002. Mol Cell Biol. 2002. PMID: 12242281 Free PMC article. - Dual control of glut1 glucose transporter gene expression by hypoxia and by inhibition of oxidative phosphorylation.
Behrooz A, Ismail-Beigi F. Behrooz A, et al. J Biol Chem. 1997 Feb 28;272(9):5555-62. doi: 10.1074/jbc.272.9.5555. J Biol Chem. 1997. PMID: 9038162 - Structural and functional analysis of hypoxia-inducible factor 1.
Semenza GL, Agani F, Booth G, Forsythe J, Iyer N, Jiang BH, Leung S, Roe R, Wiener C, Yu A. Semenza GL, et al. Kidney Int. 1997 Feb;51(2):553-5. doi: 10.1038/ki.1997.77. Kidney Int. 1997. PMID: 9027737 Review.
Cited by
- Subclinical elevated B-type Natriuretic Peptide (BNP) indicates endothelial dysfunction contributing to hypoxia susceptibility in healthy individuals.
Khatri R, Gupta RK, Vats P, Bansal V, Yadav AK, Reddy PK, Bharadwaj A, Chaudhary P, Sharma S, Bajaj AC, Deskit P, Dass D, Baburaj TP, Singh SB, Kumar B. Khatri R, et al. Life Sci. 2020 Nov 1;260:118408. doi: 10.1016/j.lfs.2020.118408. Epub 2020 Sep 12. Life Sci. 2020. PMID: 32926931 Free PMC article. - RAS oncogenic activity predicts response to chemotherapy and outcome in lung adenocarcinoma.
East P, Kelly GP, Biswas D, Marani M, Hancock DC, Creasy T, Sachsenmeier K, Swanton C; TRACERx consortium; Downward J, de Carné Trécesson S. East P, et al. Nat Commun. 2022 Sep 26;13(1):5632. doi: 10.1038/s41467-022-33290-0. Nat Commun. 2022. PMID: 36163168 Free PMC article. - Recent Insights into Roles of Hypoxia-Inducible Factors in Retinal Diseases.
Lee D, Tomita Y, Miwa Y, Kunimi H, Nakai A, Shoda C, Negishi K, Kurihara T. Lee D, et al. Int J Mol Sci. 2024 Sep 21;25(18):10140. doi: 10.3390/ijms251810140. Int J Mol Sci. 2024. PMID: 39337623 Free PMC article. Review. - Angiogenesis inhibitors: current strategies and future prospects.
Cook KM, Figg WD. Cook KM, et al. CA Cancer J Clin. 2010 Jul-Aug;60(4):222-43. doi: 10.3322/caac.20075. Epub 2010 Jun 16. CA Cancer J Clin. 2010. PMID: 20554717 Free PMC article. Review. - Cancer Metabolism as a Mechanism of Treatment Resistance and Potential Therapeutic Target in Hepatocellular Carcinoma.
Lee M, Ko H, Yun M. Lee M, et al. Yonsei Med J. 2018 Dec;59(10):1143-1149. doi: 10.3349/ymj.2018.59.10.1143. Yonsei Med J. 2018. PMID: 30450847 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous